0001179110-16-033598.txt : 20161230 0001179110-16-033598.hdr.sgml : 20161230 20161230083130 ACCESSION NUMBER: 0001179110-16-033598 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161229 FILED AS OF DATE: 20161230 DATE AS OF CHANGE: 20161230 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LPATH, INC CENTRAL INDEX KEY: 0001251769 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 161630142 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1120 SOUTH CAPITAL OF TX HWY STREET 2: BUILDING 1 SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: 512-279-5100 MAIL ADDRESS: STREET 1: 1120 SOUTH CAPITAL OF TX HWY STREET 2: BUILDING 1 SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78746 FORMER COMPANY: FORMER CONFORMED NAME: LPATH INC DATE OF NAME CHANGE: 20051202 FORMER COMPANY: FORMER CONFORMED NAME: NEIGHBORHOOD CONNECTIONS INC DATE OF NAME CHANGE: 20040323 FORMER COMPANY: FORMER CONFORMED NAME: JCG INC DATE OF NAME CHANGE: 20030702 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Remeditex Ventures LLC CENTRAL INDEX KEY: 0001627363 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35706 FILM NUMBER: 162076371 BUSINESS ADDRESS: STREET 1: 2101 CEDAR SPRINGS ROAD, SUITE 601 CITY: DALLAS STATE: TX ZIP: 75201 BUSINESS PHONE: (214) 506-2662 MAIL ADDRESS: STREET 1: 2101 CEDAR SPRINGS ROAD, SUITE 601 CITY: DALLAS STATE: TX ZIP: 75201 4 1 edgar.xml FORM 4 - X0306 4 2016-12-29 0 0001251769 LPATH, INC APEN 0001627363 Remeditex Ventures LLC 2727 N. HARWOOD STREET, SUITE 200 DALLAS TX 75201 0 0 1 0 Common Stock 2019-12-29 4 J 0 1309392 A 1309392 D Shares of common stock of the corporation then known as Apollo Endosurgery, Inc. ("Old Apollo") were converted into shares of the Issuer pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of September 8, 2016, by and among the Issuer, Merger Sub, Inc. and Old Apollo (the "Merger Agreement"). Pursuant to the terms of the Merger Agreement, each share of common stock was converted into 0.3163 shares of the Issuer's common stock. Following the merger, the Issuer effected a reverse stock split at a ratio of one new share for every five and one half shares of common stock outstanding. These securities are held directly by Remeditex Ventures, LLC. John W. Creecy is the Chief Executive Officer and Director of Remeditex Ventures, LLC and may be deemed to be the beneficial owner of the securities held by Remeditex Ventures, LLC. Mr. Creecy is a director of the Issuer and, accordingly, files separate Section 16 reports. Exhibit Index: Exhibit 24 - Power of Attorney (incorporated by reference to the Power of Attorney filed as Exhibit 24 to the Form 3 filed by the Reporting Person on December 29, 2016) /s/ Brian Szymczak - Attorney-in-Fact 2016-12-30